GSK Investigational Site

Providencia / Santiago, Región Metro de Santiago 7500710

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Anxiety Disorders, Epilepsy, Partial, Social Anxiety Disorder

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder — Completed